Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Endocrine 1

Conditions

Brain Neoplasms 23Prostatic Neoplasms 19Carcinoma, Non-Small-Cell Lung 16Lung Neoplasms 11Neoplasm Metastasis 8Melanoma 6Breast Neoplasms 6Squamous Cell Carcinoma of Head and Neck 4Pancreatic Neoplasms 4Carcinoma, Renal Cell 4Small Cell Lung Carcinoma 3Meningioma 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Sarcoma 2Prostate Adenocarcinoma 2Neoplasms 2Kidney Neoplasms 2Head and Neck Neoplasms 2Glioblastoma 2Gastrointestinal Neoplasms 2Colorectal Neoplasms 2Adenocarcinoma of Lung 2Uterine Cervical Neoplasms 1Urologic Neoplasms 1Urologic Diseases 1Urinary Bladder Diseases 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Stage II Prostate Adenocarcinoma AJCC v7 1

Interventions

Nivolumab 2veliparib 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1Taxes 1Specimen Handling 1Radiotherapy, Conformal 1Radiotherapy 1Radiosurgery 1Radiation 1Platinum 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Immunoglobulin G 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Docetaxel 1Disulfides 1Cisplatin 1Carboplatin 1CTLA-4 Antigen 1Bevacizumab 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Adenocarcinoma, Bronchiolo-Alveolar × Radiosurgery × Clear all
NCT03110978 2026-04-16

Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
140 enrolled
EndocrineThoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡